SynAct Pharma AB: cashflow_investing

Value{"amount": 370000.0, "concept": "ifrs-full:CashFlowsFromUsedInInvestingActivities"}
Period2023-01-01 – 2023-12-31
Statuscurrent
EntitySynAct Pharma AB
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference: esef:549300RRYIEFEQ72N546:2024-12-31
Retrieved: 2026-08-23T23:08:31.956949+02:00
Raw response sha256: af35ad3a3d080a3bf3479d6c365af862…
Cite as: FACTANKER, https://factanker.com/fact/fa736686-f281-4ff7-b1a5-06e3c8c6b615

History